ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Annovis Bio Inc

Annovis Bio Inc (ANVS)

28.23
0.00
(0.00%)
Closed January 18 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
28.23
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
28.23
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
10,262,000
Dividend Yield
-
PE Ratio
-0.91
Earnings Per Share (EPS)
-5.48
Revenue
-
Net Profit
-56.2M

About Annovis Bio Inc

Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-

ANVS Latest News

Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for...

FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway

MALVERN, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative...

Annovis to Host Year-End Investor Webcast on December 11, 2024

MALVERN, Pa., Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, is...

Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative...

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update

MALVERN, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for...

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative...

Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative...

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs

MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company developing transformative...

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Annovis Bio Inc. (NYSE: ANVS) announces the availability of a broadcast titled, “Transforming Alzheimer’s Treatment: Innovative...

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ANVS - Frequently Asked Questions (FAQ)

What is the current Annovis Bio share price?
The current share price of Annovis Bio is $ 28.23
How many Annovis Bio shares are in issue?
Annovis Bio has 10,262,000 shares in issue
What is the market cap of Annovis Bio?
The market capitalisation of Annovis Bio is USD 289.7M
What is the 1 year trading range for Annovis Bio share price?
Annovis Bio has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Annovis Bio?
The price to earnings ratio of Annovis Bio is -0.91
What is the reporting currency for Annovis Bio?
Annovis Bio reports financial results in USD
What is the latest annual profit for Annovis Bio?
The latest annual profit of Annovis Bio is USD -56.2M
What is the registered address of Annovis Bio?
The registered address for Annovis Bio is 1111B S GOVERNORS AVENUE, KENT, DOVER, DELAWARE, 19904
What is the Annovis Bio website address?
The website address for Annovis Bio is www.annovisbio.com
Which industry sector does Annovis Bio operate in?
Annovis Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CHROChannel Therapeutics Corporation
$ 1.90
(97.92%)
14.27M
GPUSHyperscale Data Inc
$ 4.60
(22.99%)
215.83k
VINEFresh Vine Wine Inc
$ 0.6899
(22.98%)
376.38k
RHERegional Health Properties Inc
$ 2.40
(18.81%)
227.57k
MSTUT Rex 2X Long MSTR Daily Target ETF
$ 13.245
(16.80%)
62.46M
FOXOFOXO Technologies Inc
$ 0.2295
(-27.14%)
11.34M
OSTXOS Therapies Incorporated
$ 3.03
(-26.46%)
1.63M
AEONAEON Biopharma Inc
$ 0.1401
(-18.02%)
29.86M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 12.56
(-16.32%)
26.3M
BOILProShares Ultra Bloomberg Natural Gas New
$ 67.43
(-14.52%)
3.87M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 32.49
(8.34%)
69.69M
MSTUT Rex 2X Long MSTR Daily Target ETF
$ 13.245
(16.80%)
62.46M
FXIiShares China Large Cap
$ 30.40
(1.91%)
59.69M
SPYSPDR S&P 500
$ 597.58
(1.00%)
57.17M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 18.33
(-8.03%)
53.86M

Discussion

View Full Feed
rouge Vaughn rouge Vaughn 2 minutes ago
ehmm peace seems like the rift raft is gone for now
amen now we can enjoy the silence I'm peace no posts is how it should be especially considering the price didnt drop the way they wanted it to. its holding steady
NSAV
StockItOut StockItOut 6 minutes ago
And is SP2 in on it, or got scammed?

He knows Duffy's business very well. Too well. He's the public facing legitimate player in the ruse. A shill.... Seems reasonable.
XERI
belleso belleso 7 minutes ago
I can not open the website
StockItOut StockItOut 10 minutes ago
Good DD.
XERI
gfp927z gfp927z 10 minutes ago
Bigworld, It looks like the US oligarchy may be ditching their fabricated 'climate change' strategy (links below). Blackrock, most of the big banks, and now the Fed itself, are exiting the global structures that they had previously created. Their dream of using 'climate change' as the justificat
StockItOut StockItOut 12 minutes ago
So why does a Retired Brigadeer General, an ex-CIA operative, and other supposed financial and scientific experts align with such a shifty scammer?
XERI
along4zride along4zride 20 minutes ago
Fannie Mae Inauguration Day executive order.
NOT !
Crypto:Inauguration day executive order national priority !
(FNMA) important. NOT !
Bitcoin : new hip trendy in fashion,support for innovation in the industry and asset class.
(FNMA) old worn out Fannie 
Bit
FNMA
ThunderousSeer8 ThunderousSeer8 30 minutes ago
Crowin #2 replying to Crowin profile #1. I like how you intelligently spaced out your reply this time. Very smart 😂🤡 You're a really funny guy
RDAR
JOoa0ky JOoa0ky 35 minutes ago
Wait another TEN YEARS? You out of your mind?!
FNMA
sylvia07 sylvia07 37 minutes ago
clickbait!
DBMM
bluebird50 bluebird50 40 minutes ago
I fully agree... might be a pun there!?! lol 

Hope you're doing well; maybe breakfast soon? In Vegas?? ;-)
LEHNQ
gdog gdog 41 minutes ago
One of these days the Worm will turn....

https://video.search.yahoo.com/search/video?fr=yfp-t&ei=UTF-8&p=song+who+let+the+dogs+out#id=2&vid=e14032dd9d07dd1dd9e39d33de7a02ce&action=click
NLST
jog49 jog49 42 minutes ago
"If Fannie and Freddie are fully Capitalised 21/31/2026 and Freddie 12/31/2027 why is it going to take another 10 years before dividends kick in 2034???"

They will both still be in conservatorships in 2034 because the government will have found several other ways to block exits. It wi
FNMA
quester614 quester614 45 minutes ago
Looking back at Duffy's BIO for Aegea Inc. 2013. He says that he engaged as a managing principal and in raising capital for a number of companies he founded including two bank holding companies. He also is the owner of petroleum station properties, a fast food company and commercial real estate deve
XERI
fuagf fuagf 46 minutes ago
Good point. I was thinking even Biden gave too much credit to Trump as his
team they had been on it for much longer, but missed your observation.

Will be watching for it now.
HomeRunSwing HomeRunSwing 47 minutes ago
Where will we trade when BTC hits $ 250,000 And Trump creates BTC treasury......
DEFTF
littlejohn littlejohn 47 minutes ago
Soros buying into SMCI was pumped hard on

stock twits about two weeks before

the short attack was revealed...

Don't hold me to two weeks, but it didn't

seem long after that pump before the collusion

of shorts helped implode
SMCI
johnydollar johnydollar 48 minutes ago
He got his eye balls on no bid.......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
Zorax Zorax 50 minutes ago
And the conditioned maga media keeps on ticking...shitface's name does not deserve to be first. But that is how the media always has done it for over 8 years.
It's subtle but it's almost subconscious conditioning by big media. It's like some sort of paid deal that shitfaces name always has t
mrfence mrfence 53 minutes ago
Buy the Rumor
Bessent and Ackman were at the NYSE with Trump last month
Sell Da NEWZ!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175683988

$FMCC~ $FNMA~
FMCC FNMA

Your Recent History

Delayed Upgrade Clock